Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics Study of Tolvaptan in Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload

NCT03255226 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Pediatric Congestive Heart Failure (CHF) Patients With Volume Overload

Interventions

DRUG: Tolvaptan

Sponsor

Otsuka Pharmaceutical Co., Ltd.